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VAS_baseline 49.81 50.57 1.02 0.895
VAS_3h 72.26 67.52 1.15 0.348
EQ-5D_mobility_3h 2.22 2.74 1.93 0.008
EQ-5D_self-care_3h 1.85 2.43 1.48 0.003
EQ-5D_pain_3h 1.37 1.7 1.29 0.034
VAS_4d 72.11 69 2.09 0.603
EQ-5D_mobility_4d 1.26 1.22 1.47 0.805
EQ-5D_self-care_4d 1.21 1.11 2.74 0.502
EQ-5D_pain_4d 1.42 1.5 1.39 0.673
MacNew_emotional 5.12 4.19 1.12 0.019
MacNew_total 5.27 4.51 1.02 0.088
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Background: Various methods of hemostasis have been developed for large 22 to 24Fr
femoral vein accesses for structural heart disease. Manual compression (MC) is uncom-
fortable whilst a subcutaneous stitch (SCS), which too is uncomfortable to remove, and a
double Perclose (DPC; Abbott Vascular Devices, CA) closure enables immediate
hemostasis. This study is to determine the effectiveness and safety of these methods.
Methods: 155 patients (mean age 7017years; 60(38%) female) underwent 158 valvular
therapies with the MitraClip device [n147, 93%] (Abbott Vascular, Santa Clara, CA),
Melody [n 2, 1%] (Medtronic Inc., Minneapolis, MN) or Edwards SAPIEN [n 9, 6%]
(Edwards Lifesciences LLC, Irvine, CA) valves. There were 24(16%) SCS and 99(62%)
DPC, and 35(22%) MC.
Results: There were 8(5%) access site complications (ASC): 4/35(11%) in MC (2
hematoma 1cm but 5cm, 1 hematomas 5cm requiring 2U of blood, 1 arterial-
venous fistula), 1/24(4%) in SCS (1 bleeding site requiring 1U of blood), and 3/99(3%)
in DPC (1 femoral vein thrombosis, 1 hematoma 1cm but 5cm, 1 hematoma 5 cm
requiring 2U of blood). The frequency of ASC between methods was not significantly
different (MC vs. SCS p0.33, MC vs. DPC p0.06, SCS vs. DPC p0.78). Median
length of stay was 1.01.1 days and was similar to patients that developed ASC (p0.09)
and between groups (p0.23). Protamine (median dose 3018mg) use did not influence
the frequency of ASC (2/8 protamine use with ASC vs 6/8 without ASC, p0.29). Post
procedure hemoglobin and hematocrit drop was significant (1.41.0g/dL and 4.23.5%;
both p0.01) and by comparison, this decline was significantly less for SCS
(0.71.2g/dL and 1.93.9%; both p0.01). DPC required additional strategies (like a
SCS) to attain immediate hemostasis more than SCS (26/99 (26%) vs. 1/24 (4%),
p0.02). Overall there were no in-hospital deaths, ASC related deaths and wound
infections at follow-up (mean 2018months).
Conclusions: Femoral vein closure for large 22 to 24Fr accesses, with either the SCS or
DPC method enables immediate hemostasis and reduces patient discomfort, without
compromising safety.
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Background: Same-day discharge after elective percutaneous coronary interventions
(PCI) allows a decrease in length of hospital stay, waiting list and costs with increased
patient satisfaction, but data regarding clinical features of the population with potential
benefit and safety are limited.
Methods: A consecutive group of patients who underwent elective PCI and considered
suitable for same-day discharge over a period of 4 years were enrolled. Unstable patients
with left main disease, left ventricular ejection fraction  45%, non-use of dual
antiplatelet therapy, use of oral anticoagulants or inability to reach the PCI-center within
60 minutes were excluded. Patients were examined 6 hours post-PCI and discharged if
there were no procedural complications. Clinical follow-up was carried out in all patients
after 7 days from discharge, and at 1-month and 1-year.
Results: After 981 potentially ambulatory-PCI procedures, 417 patients (42.5%) were
discharged as day cases. PCI procedures were performed by transradial (89%), trans-
femoral (9.4%), or transcubital (1.6%) approach. Mean age was 6510 years (80% male),
50% active smokers, and 27% diabetics. Most patients (62%) lived in the city area (50
km away from the PCI-hospital). Procedural success was achieved in 100% of patients.
In over 85% of patients one or two lesions in one or two vessels were treated. The mean
procedure time, mean post-PCI observation time, and mean length-of-stay after PCI were
5822 min, 6.561.24 hrs, and 10.351.41 hrs, respectively. During the procedure,
vascular complications related to the radial route were found in 9 (2.1%) patients, and
crossover from transradial to transfemoral was needed in 6 (1.4%) of patients. At 7 days
follow-up, 2 patients developed mild size hematoma on radial access site and 1 patient on
femoral access site, without any other vascular complications or major bleeding. There
were no deaths or myocardial infarction within 7 days of discharge. The 1-year mortality
rate was very low (0.2%, 1 patient).
Conclusions: Same-day discharge after elective PCI is feasible and safe with a
remarkable 1-year outcome. Its application and benefits could be extended to a broader
population of patients.
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Background: In the UK, there has been a significant change in choice of access site for
PCI driven by the desire to reduce access site complications. This has become increasingly
important with the shift to more acute PCI with the use of more potent anti-thrombotic
agents. In view of the the rapid uptake of transradial access in the UK we sought to assess
changes in outcome using nationally collected data from the British Cardiovascular
Intervention Society database.
Methods: This study includes data collected by the British Cardiovascular Intervention
Society under the auspices of the Central Cardiac Audit Database. We performed a
retrospective analysis of the BCIS database between January 2006 and December
2010.The data was split into 2 cohorts based on access site: either radial or femoral (mixed
access site use and other access sites were excluded from the analysis).
Results: Of the 370,238 procedures recorded, 223,476 (60.4%) used only transferral
access (TFA) and 124,616 (33.7%) used only transradial access (TRA). Data was missing
or mixed access was used in 22,146 (6%) of procedures. Between 2006 and 2010 TRA
for PCI increased from 17.1% to 50.8%. Over the same period, PCI for ACS increased
from 47% to 61% of procedures. 30 day mortality was 1.9% in the TFA group and 1%
in the TRA group (p  0.001). The incidence of patients presenting with cardiogenic
shock was significantly higher in the TFA group (2.1% vs 0.9%, p0.001). With shocked
and intra-aortic ballon pump (IABP) treated patients excluded, TRA remained indepen-
dently associated with a reduction in 30 day mortality (HR 0.65, CI 0.60-0.70: p0.0001)
in a multivariate analysis.
Conclusions: The majority of PCI in the UK is now undertaken using radial access. In
this large observational study, there is an association between TRA and lower 30 day
mortality. The association persists even when shock and IABP treated patients are
excluded.
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Background: Transradial approach is used as an alternative to transfemoral approach for
coronary angiography (CA) and primary coronary intervention (PCI). Transradial ap-
proach results in less access site bleeding, immediate ambulation after the procedure,
reduced length of stay and costs, less pain and improved patient comfort. However, it has
been suggested that transradial approach can lead to increased incidence of radial artery
occlusion, not allowing for repeated catheterizations from the same artery. There is limited
data on the feasibility, safety and efficacy of repeated transradial (rTR) catheterization
from the same artery. We evaluated the incidence of failure and major complications
during rTR catheterization.
Methods: We performed 3.857 catheterizations with various indications and access sites
at the American Heart Institute, in Nicosia-Cyprus, between Jan 2006 and Dec 2009. In
our center, we established TR catheterization as the routine method for elective, urgent
and emergency procedures (primary or rescue PCI). Baseline characteristics (e.g.
sociodemographics, underlying disease, smoking, prior CABG), procedural success rates
and major complications were recorded.
Results: Right rTR catheterization was attempted in 92 patients. Repeated access to the
right radial site was not possible in only 2 patients, due to poor pulse (n1), and inability
to advance the wire (n1). In 84 patients right rTR was successfully performed twice, and
in 6 patients 3 times. No major access site complications were noted in any of the above
procedures.
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